DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Easterbrook, J.
Right arrow Articles by Li, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Easterbrook, J.
Right arrow Articles by Li, A. P.

Vol. 29, Issue 2, 141-144, February 2001

Effects of Organic Solvents on the Activities of Cytochrome P450 Isoforms, UDP-Dependent Glucuronyl Transferase, and Phenol Sulfotransferase in Human Hepatocytes

Judy Easterbrook, Chuang Lu, Yumiko Sakai, and Albert P. Li

In Vitro Technologies, Incorporated, Baltimore, Maryland

We studied the effects of acetonitrile, dimethyl sulfoxide (DMSO), and methanol (MeOH) in human hepatocytes on cytochrome P450 (CYP) and phase II conjugation activities: phenacetin O-deethylation (CYP1A2), coumarin 7-hydroxylation (CYP2A6), tolbutamide 4-hydroxylation (CYP2C9), S-mephenytoin 4'-hydroxylation (CYP2C19), dextromethorphan O-demethylation (CYP2D6), chlorzoxazone 6-hydroxylation (CYP2E1), testosterone 6beta -hydroxylation (CYP3A4), and umbelliferone glucuronidation and sulfation. The solvents were evaluated at concentrations (v/v) of 0.1, 1, and 2%. Previously cryopreserved human hepatocytes pooled from multiple donors were used as suspension cultures in this study. DMSO was found to inhibit CYP2C9 and CYP2C19, CYP2E1, and CYP3A4 in a concentration-dependent manner. At 2% DMSO, the activities for the four isoforms were approximately 40% (CYP2C9), 23% (CYP2C19), and 11% (CYP2E1) of that observed for 0.1% acetonitrile and 45% (CYP3A4) of that observed for 1% acetonitrile. No apparent inhibitory effects were observed for the other activities evaluated. Methanol was found to inhibit CYP2C9 and CYP2E1 activities, but to a lesser extent than DMSO. Acetonitrile had no apparent effects on any of the on any of the activities evaluated. These findings should be considered when choosing an organic solvent for metabolism studies with human hepatocytes.

Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
A. P. Li
Evaluation of Luciferin-Isopropyl Acetal as a CYP3A4 Substrate for Human Hepatocytes: Effects of Organic Solvents, Cytochrome P450 (P450) Inhibitors, and P450 Inducers
Drug Metab. Dispos., August 1, 2009; 37(8): 1598 - 1603.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. L. Collom, R. M. Laddusaw, A. M. Burch, P. Kuzmic, M. D. Perry Jr., and G. P. Miller
CYP2E1 Substrate Inhibition: MECHANISTIC INTERPRETATION THROUGH AN EFFECTOR SITE FOR MONOCYCLIC COMPOUNDS
J. Biol. Chem., February 8, 2008; 283(6): 3487 - 3496.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
D. L. Nabb, B. Szostek, M. W. Himmelstein, M. P. Mawn, M. L. Gargas, L. M. Sweeney, J. C. Stadler, R. C. Buck, and W. J. Fasano
In Vitro Metabolism of 8-2 Fluorotelomer Alcohol: Interspecies Comparisons and Metabolic Pathway Refinement
Toxicol. Sci., December 1, 2007; 100(2): 333 - 344.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
H. S. Brown, M. Griffin, and J. B. Houston
Evaluation of Cryopreserved Human Hepatocytes as an Alternative in Vitro System to Microsomes for the Prediction of Metabolic Clearance
Drug Metab. Dispos., February 1, 2007; 35(2): 293 - 301.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
O. V. Trubetskoy, J. R. Gibson, and B. D. Marks
Highly Miniaturized Formats for In Vitro Drug Metabolism Assays Using Vivid(R) Fluorescent Substrates and Recombinant Human Cytochrome P450 Enzymes
J Biomol Screen, February 1, 2005; 10(1): 56 - 66.
[Abstract] [PDF]

Home page
 Drug Metab. Dispos.Home page
V. Uchaipichat, P. I. Mackenzie, X.-H. Guo, D. Gardner-Stephen, A. Galetin, J. B. Houston, and J. O. Miners
HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECID
Drug Metab. Dispos., April 1, 2004; 32(4): 413 - 423.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
B. Ma, M. Shou, and M. L. Schrag
SOLVENT EFFECT ON cDNA-EXPRESSED HUMAN SULFOTRANSFERASE (SULT) ACTIVITIES IN VITRO
Drug Metab. Dispos., November 1, 2003; 31(11): 1300 - 1305.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
A. Franzen, C. Carlsson, I. Brandt, and E. B. Brittebo
Isomer-Specific Bioactivation and Toxicity of Dichlorophenyl Methylsulphone in Rat Olfactory Mucosa
Toxicol Pathol, June 1, 2003; 31(4): 364 - 372.
[Abstract] [PDF]

Home page
 Drug Metab. Dispos.Home page
R. E. Pearce, G. R. Vakkalagadda, and J. S. Leeder
Pathways of Carbamazepine Bioactivation in Vitro I. Characterization of Human Cytochromes P450 Responsible for the Formation of 2- and 3-Hydroxylated Metabolites
Drug Metab. Dispos., November 1, 2002; 30(11): 1170 - 1179.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
Q. A. McKellar, C. Gokbulut, K. Muzandu, and H. Benchaoui
Fenbendazole Pharmacokinetics, Metabolism, and Potentiation in Horses
Drug Metab. Dispos., November 1, 2002; 30(11): 1230 - 1239.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.